Precipio, Inc. PRPO
Biotechnology: Laboratory Analytical Instruments · data as of November 13, 2026
Precipio, Inc. (PRPO) is a industrial company listed in the US with a market value of about $40M. In the twelve months to September 30, 2026 it had revenue of $28M and net income of -$1M, a net margin of -4.1%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a price to free cash flow of 28.6, 5-year revenue growth of 26% a year, a 5-year average ROIC of -40%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 40% below the current price.
About Precipio
Precipio is listed in the US and classified in biotechnology: laboratory analytical instruments. Revenue went from $1M in 2014 to $24M in 2025, growth of about 30.9% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 41% over three years (dilution for shareholders). It spends 7% of revenue on research and development.
Score: 2.0 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
- Debt below 3 years of free cash flow
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28M | $24M | $19M | $15M | $10M | $9M | $7M | $4M | $3M | $2M | $2M |
| Net income | -$1M | -$363000 | -$4M | -$6M | -$12M | -$9M | -$14M | -$13M | -$16M | -$21M | -$2M |
| Free cash flow | $1M | $359000 | $216000 | -$4M | -$8M | -$7M | -$8M | -$9M | -$7M | -$7M | -$978000 |
| EPS (diluted) | $-0.59 | $-0.23 | $-2.93 | $-4.51 | $-10.73 | $-8.00 | $-17.00 | $-46.60 | $-276.40 | $-2148.00 | $-2832.00 |
| Net margin | -4.1% | -1.5% | -23.2% | -38.5% | -124.3% | -96.4% | -188.0% | -323.4% | -455.2% | -1017.9% | -129.2% |
| ROIC | — | -7.0% | -32.7% | -49.5% | -73.2% | -37.5% | -59.1% | -76.6% | -185.0% | -74.5% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Precipio stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 40% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Precipio pay a dividend?
Not currently.
Is Precipio a good stock to buy?
We do not give buy or sell advice. Precipio scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.